GIF - Animal wheel interaction mid-processing .gif

The Mission

Today, 90.6% of therapies fail in human clinical trials. As a result, one drug costs an average of $2.3B and takes 12 years to get to market.

Animal studies is where the fate of therapies is decided. Once a drug has entered humans, very little can be changed.

But today, almost all animal studies are done by hand, with methods that date back to 1960s. This makes studies expensive, low throughput and irreproducible. Only about 30% of animal studies replicate even in the same animal species.

Olden is building Animal Research 2.0.

Our tech turns an ordinary cage into an automated data collection platform that captures 20 biomarkers of health continuously, at a scale and reproducibility no other existing method can match. This means lower cost studies and more reproducible studies, as well as less human bias.

If we succeed at bringing this to the world at large, the impact could be enormous.

Reducing clinical trial failure rate even by 2% would mean 10 more drugs approved per year - more than the output of the two world’s largest pharma companies combined. The impact of your work at Olden could equal that of a full Big Pharma department.

Founding In Vivo Scientist

The role. Be the first in-house scientist at Olden. You'll run the animal studies that build and validate entirely new measurements of health, cognition, strength, vision, hearing and more, and turn them into products used by labs worldwide.

Why you'll love this.

What you'll own.

What you will achieve.

Details:

You might be a fit if (Required).